Dilution has nothing to do with stock reaction. A 2 dollar deal with no warrant or options? And you think dilution is the problem? Are you kidding me? This is the most bullish deal I have ever seen for a 20 cent company. And in a way that is the problem. Its too good to be true. But, if company ever become SEC compliant(working on that now I believe) and issues updated financials and an 8k on deal or gets first sum of cash, you will see a huge delayed uptick to well over a buck. Until then, you either believe in integrity of company and buy with both hands, or wait for confirmation.
Sno, all those "wants to see" are catalysts for near term stock move. And there are others which could be positive you didn't mention. Stock has handled the dilution very well and MM, as you say, not interested in shorting here at these wide spread levels. Koreans talking with the FDA about future trial endpoints any day now.
Long termers who are not inclined to trade have no problem with wide spread(if you are not naïve, you have seen this type of trading many times with BB stocks-whinning about it endlessly is a waste of time) until more news hits. Bottom line there still is investable upside here from these levels, just not the big numbers some were hoping for.
All bb stocks are shorted in from of deals, that's just the way the corrupt system works. In one sense its a good think now, as it tends to support post deal share price after initial selloff. But, finra should still take a real look here as it seems to have been more blatant than usual.: given the sabby history and finra short #'s.
Man, if you cant figure out if a deal done on a 20 cent stock at 2 dollars!!!! (amazing) is good or bad for share price, you really shouldn't be investing.
I wouldn't put too much hope in glaucoma. CANF came out with their results for glaucoma the other day and failed. Remember, that drug was once in trials for DRy eye also. Now, doesn't mean we wont see result but you would think they would have reported by now if positive. And with that and higher price, they would have been able to get a much better finance deal. If they were to come out positive now after that private placement, you really would have to shake your head. But with JJ, anything is possible. And, it is also possible Koreans are in charge of data and haven't shared yet. Who knows.
I want to see that visual acuity # in the OSDI. That could really show a competitive advantage over the competition. Nothing to do but wait, stock not acting too badly all things considered.
But you see CEO qualities in our fearless leader: MA. And you support him as he steals from shareholders and acquiesces to the cabal of Leiberman and Castle. You have zero cred here.
A Clinton supporter? Who would have ever guessed that? And can there be anyone more expert or appreciative of the fine art of lying than reseller, the great supporter of the other great liar; MA.
You really represent the bottom of the humanity barrel, reseller.
It "tells" nothing about potential sale. They were all part of his 10b5-1 plan.
Lifetime yankee fan here, nysam. I don't think your little analogy quite holds. We don't bash the players here: tb4 and its many indications, we bash the manager: JJ. I always disliked Showalter but never gave up on the Yankees while he was manager. And yanks still mostly won. And as far as record goes, JJ is the Bucky dent of RGRX. Unfortunately, there is no Steinbrenner here, otherwise, JJ would have been history long ago.
Bottom line, just like the yanks, rgrx will survive and be profitable over time in spite of the "manager." imho
Arden, everyone(shareholder) is justifiably disappointed in this investment and has a right to express opinion in that regard. It seems every step forward is followed by two steps back. There isn't much to do but wait it out as potential still is intact, but fair future value is a little less now.
I, for one, wouldn't mind taking a couple 100 thousand of that private placement and trying to find a real CEO of value. JJ is either stupid, incompetent or corrupt.
I do intend to go to shareholder meeting and make my voice heard and let JJ know in person that we are not just faceless posters on a message board.
Are you kidding me. This is the guy we paid huge number of shares(I think 3 million) to get approval for EECP. And he got NOTHING but kept shares. What a disgrace this company is
And Simon Srybnik het 150k?!?!?!!?? For what? Just being alive?
This company gives away OUR equity likes it nothing. I am going to write GE and tell them their partner(vaso) is just an entity created to defraud its common shareholders. GE has a much higher standard of company ethics than VAso. I think they might not want to be connected with such a criminal enterprise.
Mia, I cant believe I am saying this but, good post. You are right on with that suggestion.
I don't know what some expected here. Stock is trading like any other post private placement BB stock. Timelines extended due to trial results and placement just done; should it trade higher in the short term?
Nothing nefarious going on now, just normal selling. But, all should write complaint department at Finra and ask about the possible short selling of rgrx by Sabby before the placement. Sabby has a history with the SEC.
450K shares just granted to Beecher. 150k vest right away. No wonder he feels no need to buy In the open market. Castle gets 600k, Randal gets 150k, Leiberman gets 150k
MA GETS A MILLION SHARES
How are these BUMS aligned with the common shareholder?
Disgraceful bonuses as stock sinks lower year after year. All these guys should be in Jail...............
Average call volume over all strikes on this equity is about 2100. So far, over 12k done today and over 10k in that one OTM strike. And all new positions as OI very small. Very bullish stuff
Come on B7, the funding is done for a while and back to "normal" trading. There was some size bids in the low 40's yesterday also. Sabby cant sell any shares yet, unless illegal shorting. They would have to be pretty stupid with all the attention we have put on them and Finra investigation.
And no gezzer, there is no secondary coming. Do you understand the private placement was the cash infusion?
Man sno, you are relentless in you wrongheadedness. I pointed out that Journal article to you. The point was that yes, the fda is a dogmatic piece of Sh+t. And they are NOT going to change the placebo arm for NK. SRPT has already given in and started another larger trial with a placebo arm to satisfy the FDA in hopes that they will grant AA very soon in the smaller, already finished trial which the FDA committee has voted down. They are hoping FDA chief will override committee. SRPT only agreed to placebo for second trial because FDA insisted for possible smaller trial AA. Its all a political game, as srpt will have no money for 2nd trial if AA not granted.
RGRX and Gtree will have to work with placebo, wall st journal has written at least 5 editorials on this topic to no effect.
Gtree is NOT running because of some preclinical super early data in the most competitive of all bio spaces: cancer. That new acquisition has years and millions of dollars to go. In the US market, they would value it at less than zero.
So, what else does Gtree have??????????
The recent trading you quote had no real volume and is not the main point of concern, imho. The real damage was done over the last many months where there was decent buying on the offer but new supply (short) always seemed to hold us back. 100's of thousands of shares of what appeared to be shorting (if finra #'s are right) well above that .34 price on the struggling run to .7. Stock would have been well over a buck without all that. Now, was that just normal BB nutty trading or was that, in fact, Sabby knowing that they would be covering with private placement stock. I don't know but that is the crux of the matter that should be called to finra's attention.
"can depress the stock price while they sell at a presumably higher price"
By higher price, do you mean higher than that 34 cents? Without news, Sabby aint selling any size above that number. They cant be stupid enough to think that. But, lots of potential good news that could move stock higher or solidify a higher bid in the next 6 months. I cant see a complete news vacuum in that time frame. At the very least, we will know new trial endpoints, which should be very favorable.
What I want to know and what is MOST important is this: Did Sabby short shares into this private placement. We had much documented shorting suppressing price the last couple months. And we have a known abuser of the equity finance system: caught illegally shorting Blue and CLRX into a deal. This moves the question way beyond the typical message board conspiratorial hype.
Sabby is a player. Did we get played? Everyone should write JJ and then forward a letter to the SEC and FINRA demanding an answer to that question.
Interesting investment here by Sabby and just maybe what their endgame might be someday. In 2014, Sabby was buying clrx in the 5's and 6's. Best I can tell, they had about 800k shares. Well, p2 failure tanked the stock down to less than a 2 million dollar market cap. In 2015, Celsus acquired by Akari Therapeutics in a reverse merger. Celsus had about 30 mil in NOL's. I think we have more than that right now. Anyway, don't know the exact terms of deal, and there was some additional finance done, but Akari has a 150 mil market cap right now.
So, Sabby knows what to do with NOL's and the value of monetizing them. Rgrx has to find a royalties stream with another company. So, the waiting and the drama continues.